Abstract: An implantable medical device, which comprises a device substrate, a coating on the substrate which includes a drug, and a protective layer which overlies the coating. The protective layer comprises a polymer selected from the group consisting of polylactic acid, polyglycolic acid and a lactic acid/glycolic acid copolymer having a weight average molecular weight of not more than 40,000.

Abstract: An implantable medical device, which comprises a device substrate, a coating on the substrate which includes a drug, and a protective layer which overlies the coating. The protective layer comprises a polymer selected from the group consisting of polylactic acid, polyglycolic acid and a lactic acid/glycolic acid copolymer having a weight average molecular weight of not more than 40,000.

Abstract: An implantable medical device, which comprises a device substrate, a coating on the substrate which includes a drug which is highly soluble in water, and a protective layer which overlies the coating. The protective layer comprises a polymer selected from the group consisting of polylactic acid, polyglycolic acid and a lactic acid/glycolic acid copolymer having a weight average molecular weight of not more than 40,000.

Abstract: An implantable medical device, which comprises a device substrate, a coating on the substrate which includes a drug which is highly soluble in water, and a protective layer which overlies the coating. The protective layer comprises a polymer selected from the group consisting of polylactic acid, polyglycolic acid and a lactic acid/glycolic acid copolymer having a weight average molecular weight of not more than 40,000.

Abstract: An improved process for electrostatically coating a medical device is described. Temporary conductivity is induced into the surface of a medical device whose surface is normally non-conductive. After inducing temporary conductivity to the surface of the device, it is electrostatically coated either through liquid formulation spray coating or through dry powder deposition. The process provides a high degree of uniformity and control over the coating such that the fine features of the device that are necessary for device function are carefully maintained after the coating is applied.

Abstract: A novel combination of a suture anchor and a bone void filler composition. Also, a method of using the combination to affix soft tissue to mount a suture anchor in a bone.

Abstract: Novel biodegradable bone void filler compositions. The bone void filler compositions have a biodegradable material component, an osteoconductive component, and a therapeutic agent. The bone void filler optionally contains an osteoinductive component. Also disclosed is a method of using the bone void filler compositions to fill a bone void.

Abstract: Novel biodegradable bone void filler compositions. The bone void filler compositions have a biodegradable material component, a porous osteoconductive component, and a therapeutic agent. The bone void filler optionally contains an osteoinductive component. Also disclosed is a method of using the bone void filler compositions to fill a bone void.

Abstract: Disclosed are medical devices having lubricious coatings which are capable of producing magnetic resonance image in the presence of a suitable magnetic field. The medical devices are easy to manipulate in body channels because of reduced friction with tissue surfaces and can be readily visualized in real time, which greatly facilitates the tracking of the medical devices while present within the bodies of humans or animals. The level of magnetic susceptible agent in the coatings of medical devices can be easily controlled by the present invention to give the desired performance. Coating processes to produce these medical devices are also disclosed.

Abstract: Disclosed are medical devices having lubricious coatings which are capable of producing magnetic resonance image in the presence of a suitable magnetic field. The medical devices are easy to manipulate in body channels because of reduced friction with tissue surfaces and can be readily visualized in real time, which greatly facilitates the tracking of the medical devices while present within the bodies of humans or animals. The level of magnetic susceptible agent in the coatings of medical devices can be easily controlled by the present invention to give the desired performance. Coating processes to produce these medical devices are also disclosed.